The winners of the commercial track of the AstraZeneca Skolkovo StartUp Challenge 2020 acceleration program were determined on July 2.
The contest was organized by the Skolkovo Foundation and the international Research-Based BioPharmaceutical company AstraZeneca.
The process of company selection started in April 2020 and ended in May 2020. The organizers received 170 requests.
The jury of the contest included leading Russian healthcare specialists, experts from the Skolkovo Foundation and AstraZeneca, and independent business experts (Shvabe, FRII, and Primer Capital Venture Fund).
The selection of projects was carried out in two tracks: scientific (treatment and diagnostics in the field of oncology, cardiovascular diseases, metabolism, respiratory diseases as well as medical digital solutions) and commercial (projects aimed at solving specific business problems in the areas of biopharma, oncology and improving business efficiency).
Three winners were selected for each track.
20 startups were chosen for the finals. They will have training on business communication and presentation in order to prepare for the defense of projects in the finals of the competition.
Our Webiomed project was one of the winners of the commercial track.
The award for the winners of the commercial track will be the opportunity to implement a joint project with the Russian division of AstraZeneca in 2020-2021.
"We are very happy to win and want to thank the organizers of the program for the opportunity to participate and for an interesting educational program. It is a prestigious competition which is very important for our entire team," said Alexander Gusev, Chief Business Development Officer K-SKAI Company.